Vision Medicines
Cambridge, Massachusetts, United States
About Vision Medicines
Vision Medicines is a biopharmaceutical company focused on creating innovative therapies for patients with blinding ocular diseases. The company is developing VM100 for age-related macular degeneration and VM200 for Stargardt disease, aiming to address unmet medical needs in retinal diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $7.5M
- Last round: Undisclosed (Nov 2015)
- Website: visionmedicinesinc.com
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Canonical: https://fsome.com/organization/vision-medicines-2254171 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.